New MRI model could end guesswork in Alzheimer's drug timing
NCT ID NCT07456462
First seen Mar 07, 2026 · Last updated May 20, 2026 · Updated 9 times
Summary
This study aims to develop a safer, cheaper way to monitor Alzheimer's treatment using advanced MRI scans and blood tests instead of repeated PET scans. Researchers will track 50 people with early Alzheimer's who are receiving antibody therapy (lecanemab or donanemab) to build personalized models that predict when amyloid plaques are cleared from the brain. The goal is to help doctors decide when each patient can stop treatment, reducing unnecessary procedures and improving quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MILD COGNITIVE IMPAIRMENT(MCI) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
San Raffaele Neurology Unit
Milan, Milano, 20132, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.